PRESS RELEASE published on 03/15/2023 at 13:30, 1 year 9 months ago Jaguar Health Celebrates U.N. International Day of Forests with Milestone of Providing Income to 20,000+ People Living in Tropical Rainforest Communities
PRESS RELEASE published on 03/13/2023 at 13:30, 1 year 9 months ago Jaguar Health Leveraging AI to Support Patient Access to Mytesi, the Company's FDA-Approved Prescription Drug
PRESS RELEASE published on 03/02/2023 at 14:30, 1 year 9 months ago Jaguar Health to Present at BioTrinity 2023 Conference’s R&D Spotlight on Rare Diseases
PRESS RELEASE published on 02/28/2023 at 14:30, 1 year 9 months ago FDA Grants Orphan Drug Designation to Jaguar Health for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication in the US
PRESS RELEASE published on 02/23/2023 at 14:30, 1 year 9 months ago Jaguar Health Receives Notice of Allowance for U.S. Patent for Lead FDA Approved Drug Crofelemer
PRESS RELEASE published on 02/21/2023 at 14:30, 1 year 10 months ago Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 02/09/2023 at 14:30, 1 year 10 months ago Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.
PRESS RELEASE published on 02/08/2023 at 14:30, 1 year 10 months ago Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement
PRESS RELEASE published on 02/01/2023 at 15:45, 1 year 10 months ago Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
PRESS RELEASE published on 02/01/2023 at 14:30, 1 year 10 months ago Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
Published on 12/22/2024 at 14:00, 7 hours 29 minutes ago Liberty Supports Growing Confidence Among First Home Buyers
Published on 12/21/2024 at 01:30, 1 day 19 hours ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 1 day 19 hours ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 1 day 21 hours ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:51, 1 day 20 hours ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/20/2024 at 19:10, 2 days 2 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 2 days 2 hours ago CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 2 days 3 hours ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 1 day 9 hours ago AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 1 day 9 hours ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 2 days 3 hours ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 2 days 3 hours ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 2 days 3 hours ago Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
